AS902330

BIOLOGICAL2 trials

Sponsors

Merck KGaA, Darmstadt, Germany

Conditions

Knee Osteoarthritis

Phase 1

Study of AS902330 (rhFGF-18) Administered Intra-articularly in Patients With Knee Primary Osteoarthritis Who Are Candidates for Total Knee Replacement

CompletedNCT00911469

Merck KGaA, Darmstadt, GermanyKnee Osteoarthritis

Start: 2007-11-30End: 2010-06-30Updated: 2014-08-05

A Multicenter Study of rhFGF 18 in Patients With Knee Osteoarthritis Not Requiring Surgery

CompletedNCT01033994

Merck KGaA, Darmstadt, GermanyKnee Osteoarthritis

Start: 2008-10-31End: 2010-12-31Updated: 2014-06-25

Related Papers

Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial.

2016-07-0938 citations